Sort
17,288 grants matching “multiple sclerosis”
Novel Small Molecule Inhibitor of Rheumatoid Arthritis
$184,029Jun Hayashi Hayashi · A And G Pharmaceutical, Inc. · R43 · FY2009 · AI
Stretchable electronic-bladder interface for neuroprosthetic control
$183,974Timothy M. Bruns · University Of Michigan At Ann Arbor · R21 · FY2015 · EB
Role of dysregulated miRNA in Tregs in Multiple Sclerosis
$183,953Amy E Lovett-Racke · Ohio State University · R21 · FY2013 · NS
Role of axoglial CAMs in the organization of myelinated axons
$183,909Elior Peles · Weizmann Institute Of Science · R01 · FY2014 · NS
Validation of a Motor Fatigue Measure in Multiple Sclerosis
$183,881Myla Denise Goldman · University Of Virginia · K23 · FY2012 · NS
Validation of a Motor Fatigue Measure in Multiple Sclerosis
$183,881Myla Denise Goldman · University Of Virginia · K23 · FY2013 · NS
Mucosal Therapy for Autoimmunity
$183,824David W Pascual · University Of Florida · R01 · FY2012 · AI
STAT3 and astrogliogenesis in HIV-1 associated dementia
$183,769Hui Peng · University Of Nebraska Medical Center · R21 · FY2010 · NS
Interaction Between DJ-1 and TSC1-TSC2/TOR Signaling in Cell Survival
$183,750Bingwei Lu · Palo Alto Veterans Instit For Research · R21 · FY2008 · NS
Predictive biomarkers for EAE development
$183,750Thomas G. Forsthuber · University Of Texas San Antonio · R21 · FY2015 · NS
Role of TGFBR3 in T-cell development and immune response
$183,750Chander Raman · University Of Alabama At Birmingham · R21 · FY2015 · AI
Role of CD8+ T Cells in TMEV Resistance and Susceptibility
$183,736Byung S Kim · Northwestern University At Chicago · P01 · FY2007 · NS
Molecular Basis of TMEV Persistence
$183,736Howard Lee Lipton · Northwestern University At Chicago · P01 · FY2007 · NS
Chemokin Regulation of TMEV-Induced Demyelination
$183,736William J Karpus · Northwestern University At Chicago · P01 · FY2007 · NS
CD4+ T cell Immunity in TMEV-Induced Demyelination
$183,735Stephen D Miller · Northwestern University At Chicago · P01 · FY2007 · NS
INTRANASAL NANOPARTICLE DRUG DELIVERY TO PROMOTE FUNCTIONAL RECOVERY IN MULTIPLE SCLEROSIS
$183,711Dalhousie University · · FY2022 · Department of the Army
Inhibiting axon degeneration in a mouse model of acute brain injury through deletion of Sarm1
$183,474Nils Henninger · Univ Of Massachusetts Med Sch Worcester · K08 · FY2016 · NS
Inhibiting axon degeneration in a mouse model of acute brain injury through deletion of Sarm1
$183,474Nils Henninger · Univ Of Massachusetts Med Sch Worcester · K08 · FY2017 · NS
Inhibiting axon degeneration in a mouse model of acute brain injury through deletion of Sarm1
$183,474Nils Henninger · Univ Of Massachusetts Med Sch Worcester · K08 · FY2020 · NS
MECHANISM OF COPAXONE THERAPY IN MS
$183,412University Of Texas Sw Med Ctr/Dallas · R01 · FY2002 · AI
Thalamic MRI, histopathologic, and clinical correlations in multiple sclerosis
$183,395Kedar Mahajan · Cleveland Clinic Lerner Com-Cwru · K23 · FY2018 · NS
Thalamic MRI, histopathologic, and clinical correlations in multiple sclerosis
$183,395Kedar Mahajan · Cleveland Clinic Lerner Com-Cwru · K23 · FY2020 · NS
Thalamic MRI, histopathologic, and clinical correlations in multiple sclerosis
$183,395Kedar Mahajan · Cleveland Clinic Lerner Com-Cwru · K23 · FY2019 · NS
Depression and Cognitive Impairment in Transverse Myelitis
$183,276Adam Ian Kaplin · Johns Hopkins University · K23 · FY2009 · MH
Depression and Cognitive Impairment in Transverse Myelitis
$183,276Adam Ian Kaplin · Johns Hopkins University · K23 · FY2010 · MH